Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
Earnings for Cytosorbents (CTSO)
Earnings in 2023 (TTM): -$29.33 M
According to Cytosorbents's latest financial reports the company's current earnings (TTM) are -$29.33 M. In 2022 the company made an earning of -$33.91 M a decrease over its 2021 earnings that were of -$25.3 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Cytosorbents from 2006 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$29.33 M | -13.52% |
| 2022 | -$33.91 M | 34.04% |
| 2021 | -$25.3 M | 182.17% |
| 2020 | -$8.97 M | -55.97% |
| 2019 | -$20.36 M | 14.17% |
| 2018 | -$17.84 M | 95.14% |
| 2017 | -$9.14 M | -22.32% |
| 2016 | -$11.77 M | 39.1% |
| 2015 | -$8.46 M | -12.89% |
| 2014 | -$9.71 M | 89% |
| 2013 | -$5.14 M | 26.65% |
| 2012 | -$4.06 M | -26.02% |
| 2011 | -$5.49 M | -288.45% |
| 2010 | $2.9 M | -4.17% |
| 2009 | $3.03 M | -287.19% |
| 2008 | -$1.63 M | -47.12% |
| 2007 | -$3.07 M | 41.78% |
| 2006 | -$2.17 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $1.98 B | -6,869.87% | 🇺🇸 USA |
 Hologic HOLX | $0.73 B | -2,614.57% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $55.5 M | -289.30% | 🇺🇸 USA |